Assessment of the bioequivalence.
vanderVaart
Sondra
S
Hogan
Mary-Ellen
ME
Einarson
Thomas R
TR
D000077284:Abciximab; D054058:Acute Coronary Syndrome / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics*; D003627:Data Interpretation, Statistical; D016568:Drugs, Generic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015203:Reproducibility of Results; D009626:Terminology as Topic; D013810:Therapeutic Equivalency
D000911:Antibodies, Monoclonal; D016568:Drugs, Generic; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab